FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly, to an oral liquid pharmaceutical composition containing desmopressin, and to its use in treating central diabetes insipidus, primary nocturnal enuresis, bleedings in the patients suffering hemophilia A and von Willebrand's disease, and postoperative complications.
EFFECT: invention provides stability of the pharmaceutical composition containing desmopressin, enables flexible dosage, causes no mucosal irritation.
14 cl, 4 ex
Authors
Dates
2013-02-10—Published
2008-08-01—Filed